Jasper Ridge Partners’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-12,498
| Closed | -$2.15M | – | 154 |
|
|
2021
Q3 | $2.15M | Hold |
12,498
| – | – | 0.1% | 76 |
|
|
2021
Q2 | $1.57M | Hold |
12,498
| – | – | 0.08% | 83 |
|
|
2021
Q1 | $1.7M | Hold |
12,498
| – | – | 0.08% | 75 |
|
|
2020
Q4 | $1.6M | Hold |
12,498
| – | – | 0.07% | 69 |
|
|
2020
Q3 | $1.41M | Hold |
12,498
| – | – | 0.08% | 63 |
|
|
2020
Q2 | $1.19M | Hold |
12,498
| – | – | 0.08% | 64 |
|
|
2020
Q1 | $1.12M | Hold |
12,498
| – | – | 0.09% | 56 |
|
|
2019
Q4 | $663K | Hold |
12,498
| – | – | 0.04% | 71 |
|
|
2019
Q3 | $494K | Hold |
12,498
| – | – | 0.03% | 70 |
|
|
2019
Q2 | $513K | Hold |
12,498
| – | – | 0.02% | 69 |
|
|
2019
Q1 | $582K | Hold |
12,498
| – | – | 0.02% | 59 |
|
|
2018
Q4 | $544K | Hold |
12,498
| – | – | 0.03% | 48 |
|
|
2018
Q3 | $715K | Hold |
12,498
| – | – | 0.04% | 49 |
|
|
2018
Q2 | $606K | Hold |
12,498
| – | – | 0.05% | 48 |
|
|
2018
Q1 | $489K | Hold |
12,498
| – | – | 0.03% | 47 |
|
|
2017
Q4 | $530K | Hold |
12,498
| – | – | 0.03% | 47 |
|
|
2017
Q3 | $466K | Hold |
12,498
| – | – | 0.02% | 64 |
|
|
2017
Q2 | $380K | Hold |
12,498
| – | – | 0.02% | 70 |
|
|
2017
Q1 | $331K | Sell |
12,498
-49,607
| -80% | -$1.31M | 0.02% | 82 |
|
|
2016
Q4 | $1.58M | Buy |
+62,105
| New | +$1.97M | 0.11% | 48 |
|
Jasper Ridge Partners's XLRN Position: Q4 2021 in Review
Jasper Ridge Partners sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 12,498 shares — an estimated $2.15M sold.
Jasper Ridge Partners first reported a position in XLRN in Q4 2016 and held it in 20 quarters. The position peaked at $2.15M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- Jasper Ridge Partners reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- Jasper Ridge Partners sold 12,498 Acceleron Pharma shares in Q4 2021, an estimated $2.15M.
- Jasper Ridge Partners first reported a position in Acceleron Pharma in Q4 2016 and held it in 20 quarters.
- Jasper Ridge Partners's Acceleron Pharma position peaked at $2.15M in Q3 2021.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on Jasper Ridge Partners's 13F filing for Q4 2021, filed 11 Feb 2022.